
Business Update22 Jun 2024, 11:05 pm
Sudarshan Pharma Achieves Milestone in Manufacturing Vitamin B1 Finish API
AI Summary
Sudarshan Pharma Industries Ltd has successfully completed the first milestone in the development and manufacturing of Vitamin B1 (Thiamine Hydrochloride) finish API. The project was awarded under the Aatmanirbhar Bharat Rojgar Yojana (ABRY) scheme. The development of the molecule took place at Prin. K. M. Kundnani College of Pharmacy, Mumbai, under the research team of Dr. Shrikant Ghodse. The company has successfully manufactured all the intermediate products required to manufacture the finish API. Sudarshan Pharma is the first time in India to manufacture Vitamin B1 from the base root and is filing for a patent for the manufacturing process.
Key Highlights
- Sudarshan Pharma achieves first milestone in Vitamin B1 (Thiamine Hydrochloride) finish API manufacturing
- Project awarded under Aatmanirbhar Bharat Rojgar Yojana (ABRY) scheme
- Development of the molecule took place at Prin. K. M. Kundnani College of Pharmacy, Mumbai
- Company has successfully manufactured all intermediate products for the finish API
- Sudarshan Pharma is the first in India to manufacture Vitamin B1 from the base root and filing for a patent